Aceto Corporation  

(Public, NASDAQ:ACET)   Watch this stock  
Find more results for ACET
21.04
-0.15 (-0.71%)
Nov 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 20.95 - 21.41
52 week 16.52 - 25.25
Open 21.41
Vol / Avg. 105,921.00/220,251.00
Mkt cap 611.53M
P/E 26.89
Div/yield 0.06/1.14
EPS 0.78
Shares 29.07M
Beta 1.60
Inst. own 75%
Feb 4, 2015
Q2 2015 Aceto Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 4, 2014
Aceto Corp Annual Shareholders Meeting - 10:00AM EST - Add to calendar
Nov 20, 2014
Aceto Corp at Furey Research Partners "Hidden Gems" Conference
Nov 20, 2014
Aceto Corp at Singular Research Best of the Uncovereds Conference
Nov 7, 2014
Q1 2015 Aceto Corp Earnings Call - Webcast
Nov 6, 2014
Q1 2015 Aceto Corp Earnings Release
Sep 5, 2014
Q4 2014 Aceto Corp Earnings Call - Webcast
Sep 4, 2014
Q4 2014 Aceto Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 3.69% 5.68%
Operating margin 6.59% 8.68%
EBITD margin - 10.26%
Return on average assets 4.17% 7.33%
Return on average equity 8.27% 13.54%
Employees 270 -
CDP Score - -

Address

4 Tri Harbor Ct
PORT WASHINGTON, NY 11050-4661
United States - Map
+1-516-6276000 (Phone)
+1-516-6276093 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aceto Corporation (Aceto) is primarily engaged in the sourcing, regulatory support, quality assurance, marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries. The Company operates in three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Company has presence in China, Germany, France, the Netherlands, Singapore, India, Hong Kong, the United Kingdom and the United States, along with warehouses worldwide. In May 2014, the Company completed the acquisition of PACK Pharmaceuticals, LLC.

Officers and directors

Albert L. Eilender Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Salvatore J. Guccione President, Chief Executive Officer, Chief Operating Officer, Director
Age: 51
Bio & Compensation  - Reuters
Douglas A. Roth Chief Financial Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Satish Srinivasan President and Chief Operating Officer of Rising Pharmaceuticals
Age: 45
Bio & Compensation  - Reuters
Steven Rogers Senior Vice President, General Counsel, Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Charles J. Alaimo Senior Vice President - Human Resources
Age: 48
Bio & Compensation  - Reuters
Raymond Bartone Senior Vice President - Nutritionals
Age: 52
Bio & Compensation  - Reuters
Frank V. DeBenedittis Senior Vice President - Corporate Business Development
Age: 60
Bio & Compensation  - Reuters
Terry Kippley Senior Vice President - Agricultural Protection Products
Age: 50
Bio & Compensation  - Reuters
Carlos Restrepo Senior Vice President - Performance Chemicals
Age: 52
Bio & Compensation  - Reuters